2014年1月21日 星期二

老年醫學: 維生素D可預防跌倒
(Geriatrics Society Guidelines: Vitamin D May Prevent Falls)
Older patients should receive sufficient vitamin D intake from all sources to lower their risk for falls and fractures, according to a new consensus statement published online December 18 in the Journal of the American Geriatrics Society. Dietary sources, sunlight, and supplements can all contribute to vitamin D levels of around 30 ng/mL (75 nmol/L), which appears to protect against fall-related injuries.
"In studies that achieved average serum levels greater than 25 ng/mL, falls and fracture rates were significantly reduced," James Judge, MD, chair of the American Geriatrics Society's (AGS's) Consensus Statement on Vitamin D Supplementation for Older Adults Work Group, told Medscape Medical News. "The impact on fractures is most likely due to the reduction in falls. In older adults, the impact of vitamin D on bone density is very small, while the impact on falls is measurable."
The consensus statement targets primary healthcare providers, aiming to help them ensure that community-dwelling and institutionalized older adults receive adequate vitamin D from all available sources. In addition to incorporating evidence from recent high-quality research, the statement is based on input from several medical organizations.
The health and well-being of older adults depends on fall and fracture prevention. Previously independent older adults often have to enter long-term care institutions because of repeated falls, and half of all nursing home residents older than 65 years have at least a single fall annually. Hip fracture is one of the most serious consequences of an elderly person falling, as it typically leads to long-term disability, untimely nursing home admission, and premature mortality.
Calcium absorption, healthy bone density, and physical function all require adequate vitamin D levels, and calcium is also vital for bone health. In addition, low Vitamin D levels are linked to muscle weakness, loss of bone strength, and falls and fractures.
Sources of vitamin D include fortified milk and other fortified foods, supplements, and production by the skin when exposed to sunlight (which becomes significantly less efficient with advancing age). In addition, sunlight exposure can cause skin cancer and excess exposure should be avoided. Therefore, the elderly are especially likely to need vitamin D supplementation.
The AGS workgroup agreed with the Endocrine Society (2011), the Osteoporosis Canada Statement (2010), and the majority opinion of the International Osteoporosis Foundation (2010) that a vitamin D [25(OH)D] serum concentration of 30 ng/mL (75 nmol/L) was safe and would ensure the full benefit of vitamin D for older adults.
"For the population of older adults, a total average daily intake from all sources (diet, supplement, and sunlight) of 4000 IU will ensure that 90% of the population will achieve serum 25(OD) D levels of 30 ng/mL," said Dr. Judge, who is also a member of the AGS Clinical Practice Committee, associate clinical professor of medicine at the University of Connecticut School of Medicine in Farmington, and senior medical director of Optum in Eden Prairie, Minnesota.
"This is the serum level that will maximize the protection from falls and fractures that vitamin D can provide," Dr. Judge continued. "The Institute of Medicine (IOM) determined that [a] 4000 IU daily supplement is safe and can be given without risk of toxicity."
The committee used dose–response calculations included in the 2011 IOM report to determine the total vitamin D intake that would achieve recommended serum levels in 92% or more of older adults.
Recommendations for Clinicians to Ensure Adequate Vitamin D Levels in Older Adults
  • Review the report and the vitamin D dose–response curve indicating that 1000 IU daily will achieve recommended vitamin D levels in only half of older adults and that substantially higher doses are needed to achieve these levels in 90% of patients.
  • Review older patients' vitamin D intake from dietary, sunlight, and supplement sources and discuss strategies to achieve a total vitamin D input of 4000 IU/day.
  • Discuss strategies for adequate vitamin D and calcium supplementation with older adults and their caregivers. Available evidence does not support a recommendation for increased vitamin D supplementation without calcium for older people. Supplemental calcium doses in most studies range between 500 and 1200 mg daily.
  • Help older adults and their caregivers choose the vitamin D and calcium supplementation schedule they are most likely to follow. Various vitamin D supplements may be taken daily, weekly, or monthly, and different combinations of calcium and vitamin D supplements are available.
"Vitamin D supplementation weekly, biweekly, monthly and up to every 3 months is OK," Dr. Judge said. "To maximize absorption, the vitamin D supplements should be taken with meals that provide some fat or oils. Understanding your patient's preferences will help you provide a dosing strategy that they can sustain."
Dr. Judge added that clinicians generally do not need to measure vitamin D levels in patients receiving adequate supplementation. The exceptions are patients with obesity, defined as a body mass index (BMI) higher than 30 kg/m2 or body mass higher than 90 kg; malabsorption syndromes; and/or use of medications that either bind vitamin D in the gut or accelerate the breakdown of vitamin D. These medications include cholestyramine and inducers of the cytochrome P450 pathway, such as phenytoin and phenobarbital.
A table included in the AGS statement can help clinicians determine which patients are in need of higher supplement doses and how they can easily determine how much they need based on dietary, sunlight, and supplement exposure.
"We know that in populations, vitamin D levels in the late summer/fall are higher...and our best estimate is that the seasonal variation in total vitamin D generation from sunlight is roughly 1000 IU [a] day," Dr. Judge said. "We know that obese persons have lower vitamin D levels and will need more supplementation. Deeper pigmentation is associated with lower vitamin D levels, but there is evolving information (not available when the statement was completed) that vitamin D levels in African-Americans may not reflect the bioavailability of vitamin D."
Dr. Judge pointed out that most Americans report dietary intake of 150 to 225 vitamin D units daily, with the majority coming from fortified dairy products. Salmon, tuna, mackerel, sardines, and shitake mushrooms provide about 200 IU per serving. Milk products and fortified yogurts provide about 100 IU per 8-ounce (240 cc) serving.
When asked about the need for additional research, Dr. Judge commented that the recommendations of the AGS are based on limited evidence.
"It would be very helpful to clinicians if there were more accurate dosing algorithms than the one presented in this statement," he concluded. "There is limited evidence that 90% of normal-weight older adults (BMI < 25) will achieve recommended serum levels with 1600 to 2000 IU daily supplements. Overweight and obese adults require higher daily supplements — up to 4000 IU daily to achieve serum levels of 30 ng/mL."
Dr. Judge has disclosed no relevant financial relationships.
J Am Geriat Soc. Published online December 18, 2013. Full text

2014年1月9日 星期四

Hyperkalemia  (Serum K > 5.0 mEq/L or 5 mmol/L)
Signs & Symptoms of Hyperkalemia:
The symptoms of hyperkalemia are related to impaired neuromuscular transmission (nonspecific Sx).
The earliest findings are paresthesias and weakness, which can progress to paralysis affecting respiratory muscles. 鉀多感弱麻痺呼吸肌中樞無恙
These symptoms are similar to those seen with hypokalemia; cranial nerve function, however, characteristically remains unaffected.
EKG changes: increase T, S ,PR interval, QRS interval; decreased P, R, ST segment; 2-3 AV block; atrial or vent. arrhythmia
  • Serum K 5.5 - 6.5 mEq/L: peaked T waves; prolonged PR segment
  • Serum K 6.5 - 8.0 mEq/L: loss of P wave, prolonged QRS complex, ST-segment elevation, ectopic beats and escape rhythms
  • Serum K > 8.0 mEq/L: progressive widening of QRS complex, sine wave, ventricular fibrillation, asystole, axis deviations, bundle branch blocks, fascicular
Figure 1
  • Hyperkalemia ECG

    Hyperkalemia can cause life-threatening arrhythmia and thus recognizing hyperkalemia on the ECG is crucial. The ECG findings of hyperkalemia change as the potassium level increases. From slightly high levels to very high levels, ECG findings include:
    1.  Peaked T waves best seen in the precordial leads, shortened QT interval, and sometimes ST segment depression.
    TWaves2
    2.  Widening of the QRS complex (usually potassium level is 6.5 or greater). This frequently appears as in "non-specific intraventricular conduction delay" or IVCD which is characterized by a widened QRS complex of > 120 ms that does not meet the criteria for a left or right bundle branch block. Frequently an IVCD will look like a left bundle branch block in lead V1 with a rS complex or monomorphic S wave and it appears like a right bundle branch block in leads I and V6 with a broad, slurred S wave.
    CLINICAL PEARL: If you see an IVCD, think of hyperkalemia.
    3.  Decreased amplitude of the P waves, an increase in the PR interval, and bradycardia in the form of AV blocks occur as the potassium level exceeds 7.0.
    CLINICAL PEARL: Supportive measurements like fluids, pacing, and pressors do not work in the setting of hyperkalemia. You must treat the hyperkalemia first.
    4.  Absence of the P waves and eventually a "sine wave" pattern (see below) which is frequently a fatal rhythm.
    Hyperkalemia
    CLINICAL PEARL: Giving intravenous calcium is "cardioprotective" in the setting of hyperkalemia. Frequently instant reversal of all hyperkalemic ECG changes within seconds of administration. Calcium does not decrease the potassium levels, so other therapy like bicarbonate or insulin is needed to do this. Calcium administration can be fatal when digoxin toxicity is causing hyperkalemia and should be avoided.
  • Treatment of Hyperkalelmia   Discontinuance of all medications that adversely affect potassium balance is mandatory in true hyperkalemia, particularly when it is severe (plasma [K+] > 6.0 mEq/L).
    These medications include nonselective beta blockers, ACE inhibitors, potassium-sparing diuretics, NSAIDs, and trimethoprim. Salt substitutes, which contain potassium chloride, should also be avoided. Persons with mild hyperkalemia (plasma [K+] < 6.0 mEq/L) can usually be treated conservatively with reduction of daily intake to less than 2 g and, if indicated, with the addition of a loop diuretic.
    Algorithmic management of Hyperkalemia Is life-threatening hyperkalemia present? (ECG changes?  Serum K > 6.5 mEq/L? High-risk as renal failure, receiving dialysis, causative medications?) A.  If No (Life-threatening hyperkalemia is not present) --> Resin exchange with laxative, loop diuretic as furosemide, dialysis
    • Kayexalate (Na Polystyrene Sulfonate) 30 gm in 100 cc 20% sorbitol PO q3-4h. Kayexalate 50 gm in 200 cc 20% sorbitol retention enema 30- 60 min q 4- 6h (decreased 0.5-1 meqK)
    • Furosemide (Lasix) 40-80-160 mg IV
    • Dialysis
    B.  If Yes (life-threatening hyperkalemia is present)--> Step 1: Stabilize the myocardium: (IV Calcium infusion) 
    • IV Calcium Chloride (27.2 mg/dL calcium) or Calcium gluconate  (8.8 mg/dL calcium) 10 mL (1 amp) of 10% solution (500-1000 mg)
      IV infusion over 2-3 minutes.
      * Be extra careful when using calcium infusion in patients with concurrent digitalis toxicity, it could worsen brady-arrhythmia and potentially cause cardiac arrest; use EKG monitor.
      - for slow infusion, may give the calcium solution in 250 mL D5W and given over 30 minutes.
    Step 2: Shift potassium into cells:  (IV glucose +/- insulin +/- Na bicarbonate; Albuterol nebulizer Rx or IV infusion)
    • IV 25 - 50 gm of glucose (25-50 g = 1-2 ampules of 50% dextrose D50W or 250-500 mL of D10W solution) +/- IV Regular insulin 10 units
      - may add Na HCO3 7.5% 50 cc amp 1 -2 amp in the setting of substandial metabolic acidosis (bicarbonate <22 mEq/L)
    • Albuterol  nebulizer Rx can be administered at a dosage of 10 to 20 mg in 4 ml of saline by nasal inhalation over 10 minutes or by a 0.5 mg I.V. infusion.
      - Beta-agonists decrease plasma potassium levels.  Albuterol can be given via a nebulizer (10-20 mg in 4 mL of saline) or via IV infusion (0.5mg).  The dosages of B-agonists administered in this setting are relatively high, ranging from 4 to 8 times that recommended for Rx of an acute asthma exacerbation).  The major adverse effects are tremor, tachycardia, anxiety, and flushing.
    Step 3:  Enhance elimination of potassium:  (Kayexalte, Lasix, Dialysis)
    • Resin exchange with laxative: Kayexalate (Na Polystyrene Sulfonate) 30 gm in 100 cc 20% sorbitol PO q3-4h. Kayexalate 50 gm in 200 cc 20% sorbitol retention enema 30- 60 min q 4- 6h (decreased 0.5-1 meqK)
    • Loop diuretic as furosemide (Lasix) 40-80-160 mg IV
    • Hemodialysis - It is the Rx of choice for life-threatening hyperkalemia that is refractory to medical management.  It may decrease the serum K level by 1.0 - 1.5 mEq/L for each hour of dialysis.
    REF: Mayo Clinic Proceedings Dec 2007   * If aldosterone deficiency has been documented in cases of chronic hyperkalemia that are inadequately controlled by diet or diuretics, aldosterone replacement with fludrocortisone acetate may be useful. The combination of fludrocortisone and a loop diuretic may limit the development of hypertension or edema. However, because its onset of action may take several days or longer, this therapy is not sufficiently effective to be used in the treatment of acute, life-threatening hyperkalemia.
  • Diff. Dx:A. Pseudohyperkalemia (Factitious hyperkalemia)
    1. Improper blood collection (lab error)
    2. Hematologic disorder with increased WBC or platelets B. Exogenous potassium load
    1. Oral or IV potassium supplement intake
    2. Potassium containing drugs
    3. Transfusion C. Decreased renal potassium excreation
    1. Renal failure: acute or chronic
    2. Potassium sparing diuretics or ACE-inhibitors
    3. Mineralocorticoid deficiency
        a. Addison's disease or  Bilateral adrenalectomy
        b. Hypoaldosteronism
           (1) Hyporeninemic hypoaldosteronism
           (2) Heparin therapy
           (3) Specific enzyme defect or Tubular unresponsiveness
    4. Congenital adrenal hyperplasia or Primary defect in potassium excretion D. Cellular shift of K+
    1. Tissue damage: trauma, burns, rhabdomyolysis;   Destruction of tumor tissue
    2. Acidosis
    3. Digitalis overdose; Hyperosmolality
    4. Hyperkalemic periodic paralysis
    5. Succinylcholine, Arginin infusion